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Dr Jeffrey P. Carpenter (Philadelphia, Pa). Drs Dillavou and
Makaroun have enlarged our understanding of thoracic aortic repair
by identifying some preoperative risk factors for morbidity and mor-
tality after both open and TEVAR [thoracic endovascular aneurysm
repair] approaches using the TAG [W. L. Gore and Associates,
Flagstaff, Ariz] database. They have identified a number of risk factors,
which unfortunately cannot be modified, that predict bad outcomes:
gender, height, renal function, presentation, and age, among those.
I would ask, therefore, what is our take-homemessage regard-
ing patient selection for open or endovascular repair from these
data? Howwould you reduce these findings to actual practice? Can
you tell us a little more about the endoleak rate of 10.6%? Are these
mostly type II leaks, or are they attachment or junction leaks? Also,
could you comment on that sac expansion rate of 19%. Is that
endotension as we saw with the abdominal excluder, or is this a
different problem with the TAG? What have your investigators
done about that issue, and what is recommended?
Also, I am fascinated by your finding in the manuscript, which
you provided to me, that the short proximal neck length predicted
perioperative morbidity. Perhaps that is a modifiable risk factor.
What are the practical implications of this short neck finding
related to morbidity?
And then, finally, in light of the finding of prospective ran-cular means, specifically that there is no long-term mortality ben-
efit to EVARwhen compared with open aneurysm repair. Payment
has been denied for EVAR in parts of Europe. EVAR is under very
careful scrutiny by payers in this country as well.
Now, I know the TAG database is not a randomized study of
open vs endovascular repair of thoracic aneurysms, but it remains
the best available data set we have for comparison between open
and endovascular groups. Do you have any glimpse of the long-
term comparison of mortality between those groups? Does the
mortality benefit in the perioperative period that you noted extend
to the longer term?
Dr Dillavou. Thank you, Dr Carpenter. Going through the
questions one by one, you ask an excellent question about what is
the take-home message from these data. I agree that some factors
cannot be changed. However, I believe that we can use this
information to educate patients and to enhance patient selection.
Some proactive measures can also be taken. For instance, if we
know that women have a higher chance of vascular complications
after TAG endografting, perhaps planning a conduit is the better
choice rather than just deciding to forge through.
You ask about the endoleak rate of 10.6% at 5 years.We found that
most of thesewere attachment site leaks, and theywere fixed relatively
easily over time. Only three patients have had to undergo conversion,
two were for aortoenteric fistulas and one was for proximal migration
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for endoleaks. All were able to be treated percutaneously.
The sac expansion rate of 19% at 5 years is something that
deserves attention. A few patients had endoleaks, but the vast
majority of them did not. We attribute sac expansion to the same
forces and porosity that we see in the abdominal group. All of these
TAG grafts that were put in were the standard expanded PTFE
[polytetrafluoroethylene] grafts.
Comparing these grafts to the low-porosity TAGs showed
differences that did not achieve statistical significance; at 2 years in
the low-porosity group, we saw a 3% sac expansion vs a 13% sac
expansion in the regular group. We hope that the low-porosity
graft will decrease sac expansion. Thus far, no action has been taken
on these patients if no endoleak is found.
You ask about short proximal neck length related to perioperative
morbidity. We have found that with carotid–subclavian bypass, there
is a statistically higher incidence of stroke after endografting. This is
true whether or not the carotid–subclavian bypass was done preoper-
atively or immediately postoperatively.Wehypothesize that this is due
to a more diseased arch and more manipulation. All strokes were
perioperative events. This is something to take into consideration
when planning the operation and educating the patient.
Finally, you ask about our results and compared them to the
EVAR I and II trials done in the United Kingdom. We found that
there was a significant aneurysm-related survival difference, with a
higher aneurysm-related survival in the thoracic endograft group
compared to the open surgical group. However, looking at overall
mortality, there was no difference between the groups at 5 years. So
there is a difference in aneurysm mortality, and it persists to 5 years.
Dr Keith D. Calligaro (Philadelphia, Pa). Dr Dillavou, very
nice presentation. I know this was retrospective and you can’t really
match up the patients. The question is whether patients who
underwent open surgical repair did so because they did not have an
adequate neck proximal or distal? If there wasn’t an adequate
landing zone for an endograft, more of the patients undergoing
open repair might require clamping above the subclavian or below
the viscerals and that alone would increase the morbidity.
Dr Dillavou. No. The clamp site limits were basically the same
for both groups, that the proximal clamp could not have been placed
more proximal then the left carotid artery and the distal clamp could
not be placed more distally than the celiac trunk. So the clamp sites
were the same. Some of these were historic controls that were done
prior to the availability of the endovascular graft.
DrMaciej L. Dryjski (Buffalo, NY). I have a question regarding
the mortality. How would you explain the higher mortality in the
symptomatic group of patients? Is it perhaps that the symptoms were
not related to the aneurysm itself, but rather some other medical
condition?Dr Dillavou. To make sure I understand your question, you
are asking if I believe that the increased mortality in the symptom-
atic aneurysm group was because of hemodynamic instability and
presentation?
Dr Dryjski. Were these patients hemodynamically unstable,
or were the symptoms related to some other condition, not neces-
sarily an expanding aneurysm?
Dr Dillavou. These were not hemodynamically unstable pa-
tients. There was no one with a rupture or a leak or anything like
that. These were patients who presented, whom the surgeon felt
were having pain or other symptoms due to the aneurysm, and in
most cases they were done more urgently than a traditional
planned aneurysm repair. It is my hypothesis that part of the reason
that these patients have an increased mortality is because that their
operations probably were less electively planned. We did not find
any difference in operating room blood loss or other intraoperative
factors, hematocrit values, things like that.
Procedure times were slightly longer for symptomatic vs non-
symptomatic aneurysms, but there again, that just may be related
to the more difficult nature of the anatomy. There is no concrete
reason why the symptomatic aneurysm group had such a dramatic
increase in mortality, but my hypothesis is just that the patients
were not optimized prior to their repairs. Also, some of these
patients may not have been offered elective surgery due to ana-
tomic or medical factors, but because they presented symptomat-
ically they underwent a repair.
Dr Marat Goldenberg (Reading, Pa). I have a two-part
question. You said that in women the operative time was longer.
Question number 1, do you think this is due to the smaller access
vessels or unique characteristics of the aneurysm? Do you think
they have higher level of complication because of the longer time
under anesthesia or the degree of difficulty?
Dr Dillavou. That’s an excellent question. I believe that the
longer procedure times were probably related to smaller access
vessels and also to complications that were encountered in the
operating room. More than half of the vascular complications that
we saw were actually dealt with at the time of the procedure—iliac
artery ruptures, femoral artery occlusions, et cetera—and so this
obviously adds to procedure time. It is my belief that this, the
difficult access, is the cause and the long procedure time is the
effect, although it is impossible to know for sure.
That is something that we struggled with statistically in this
database, and that is that long procedure times, no matter what we
were analyzing, long procedure times predicted bad outcomes. But
we also saw predictably longer procedure times with open surgery
and in patients with complications, which all sort of goes together.
And so it is my hypothesis that the long procedure times were an
effect rather than the cause of the morbidities.
